Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 45 Breast Neoplasms 20 Myelodysplastic Syndromes 19 Prostatic Neoplasms 12 Neoplasms 12 Leukemia, Myelomonocytic, Chronic 12 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Esophageal Neoplasms 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Ovarian Neoplasms 6 Multiple Myeloma 6 Lung Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 5 Esophageal Squamous Cell Carcinoma 5 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3

Interventions

tislelizumab 1 pamiparib 1 Injections 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locally Advanced Prostate Cancer × Injections × Clear all

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡